Miglustat

Details

Files

Generic Name:

Miglustat

Project Status:

Complete

Therapeutic Area:

Gaucher disease

Manufacturer:

Actelion Pharmaceuticals Canada Inc.

Brand Name:

Zavesca

Project Line:

Reimbursement Review

Project Number:

SR0012-000

Submission Type:

Initial

Indications:

Gaucher disease

Recommendation Type:

Do not list

Final Recommendation:

November 24, 2004

Recommendation:

Not to list.

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : May 13, 2004